Medicine and Dentistry
Phosphoinositide 3-Kinase
100%
LY294002
100%
Lymphoblastoid Cell
100%
Epstein Barr Virus
66%
Lymphoblastoid Cell Line
66%
Cell Cycle
66%
Burkitt's Lymphoma
66%
Posttransplant Lymphoproliferative Disease
66%
B Lymphocyte
66%
B Cell
33%
B-Cell Lymphoma
33%
Protein Family
33%
Growth Inhibition
33%
Diagnosis
33%
Cell Cycle Progression
33%
Lymphoma Cell
33%
Signaling Molecule
33%
Proliferating Cell Nuclear Antigen
33%
Cyclin Dependent Kinase Inhibitor
33%
Cyclin
33%
Dephosphorylation
33%
Cyclin D3
33%
Cyclin D2
33%
G1 Phase
33%
Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Lymphoblastoid Cells
100%
LY294002
50%
Epstein-Barr Virus
33%
Lymphoblastoid Cell Lines
33%
Burkitt Lymphoma
33%
B Lymphocytes
33%
Transcriptional Activity
33%
Post-transplant Lymphoproliferative Disorder
33%
B Cells
16%
Latent Membrane Protein 1 (LMP1)
16%
Growth Inhibition
16%
Cell Cycle Progression
16%
G1 Phase
16%
B-cell Lymphoma
16%
Cyclin-dependent Kinase Inhibitor
16%
Active Form
16%
Latent Genes
16%
Protein Family
16%
Signaling Molecules
16%
Cyclin D3
16%
D2-D3
16%
Chemical Inhibitors
16%
Cyclin D2 (CCND2)
16%
P27Kip1
16%
Cell Cycle Entry
16%
Dephosphorylation
16%
Growth Regulation
16%
Cyclin
16%
Pocket Proteins
16%
Treatment Opportunity
16%
D-type Cyclins
16%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Phosphoinositide 3-Kinase
100%
LY294002
75%
Epstein Barr Virus
50%
Cell Cycle
50%
E2F
50%
G1 Phase
25%
Cell Cycle Progression
25%
Cyclin-Dependent Kinase
25%
Cyclin D3
25%
Growth Inhibition
25%
Cyclin D2
25%
Dephosphorylation
25%
Cyclin
25%
Proliferating Cell Nuclear Antigen
25%
Pocket Protein Family
25%
Immunology and Microbiology
B Cell
100%
Lymphoblastoid Cell
100%
Cycline
75%
Lymphoblastoid Cell Line
50%
Epstein Barr Virus
50%
Cell Cycle
50%
Lymphoma Cell
25%
Protein Family
25%
Growth Inhibition
25%
Cell Cycle Progression
25%
Cell Cycle G1 Phase
25%
Cyclin D2
25%
Dephosphorylation
25%
Cyclin D3
25%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphatidylinositol 3 Kinase
100%
2 Morpholino 8 Phenylchromone
100%
Epstein-Barr Virus
66%
Burkitt's Lymphoma
66%
Cycline
66%
Posttransplant Lymphoproliferative Disease
66%
Cyclin Dependent Kinase Inhibitor
33%
B Cell Lymphoma
33%
Cyclin D3
33%
Cyclin D2
33%